Дарья Устьянцева (редактор отдела «Мир»)
CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
，更多细节参见服务器推荐
Жители Санкт-Петербурга устроили «крысогон»17:52
For security reasons this page cannot be displayed.